Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
55,268,018
-
Share change
-
+1,965,724
-
Total reported value
-
$265,807,215
-
Price per share
-
$4.81
-
Number of holders
-
109
-
Value change
-
+$8,515,683
-
Number of buys
-
55
-
Number of sells
-
36
Institutional Holders of GENMARK DIAGNOSTICS INC - COM (GNMK) as of Q4 2019
As of 31 Dec 2019,
GENMARK DIAGNOSTICS INC - COM (GNMK) was held by
109 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
55,268,018 shares.
The largest 10 holders included
FMR LLC, CADIAN CAPITAL MANAGEMENT, LP, MORGAN STANLEY, BlackRock Inc., Casdin Capital, LLC, VANGUARD GROUP INC, Bellevue Group AG, HighTower Advisors, LLC, PRICE T ROWE ASSOCIATES INC /MD/, and BANK OF AMERICA CORP /DE/.
This page lists
109
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.